Profit Margin (Quarterly) Chart

View Profit Margin (Quarterly) for ORXOF.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Profit Margin (Quarterly) Chart
Start Trial

Historical Profit Margin (Quarterly) Data

View and export this data back to 2004. Start Trial.
Date Value
March 31, 2026 -2.10K%
December 31, 2025 -3.50K%
September 30, 2025 -25.10%
June 30, 2025 -33.67%
March 31, 2025 -686.3%
December 31, 2024 -72.49%
September 30, 2024 -30.70%
June 30, 2024 -23.31%
March 31, 2024 -6.39%
December 31, 2023 -11.20%
September 30, 2023 -21.33%
June 30, 2023 -7.99%
March 31, 2023 -40.24%
December 31, 2022 -58.81%
September 30, 2022 -16.46%
June 30, 2022 -24.22%
March 31, 2022 -14.81%
December 31, 2021 -45.76%
September 30, 2021 -35.64%
June 30, 2021 -51.61%
March 31, 2021 -23.81%
December 31, 2020 -31.16%
September 30, 2020 -56.49%
June 30, 2020 -18.15%
March 31, 2020 47.20%
Date Value
December 31, 2019 16.34%
September 30, 2019 48.31%
June 30, 2019 27.14%
March 31, 2019 8.09%
December 31, 2018 22.72%
September 30, 2018 28.72%
June 30, 2018 25.09%
March 31, 2018 -18.54%
December 31, 2017 13.98%
September 30, 2017 16.97%
June 30, 2017 1.95%
March 31, 2017 -27.16%
December 31, 2016 18.03%
September 30, 2016 19.79%
June 30, 2016 2.66%
March 31, 2016 -22.85%
December 31, 2015 -22.69%
September 30, 2015 -33.05%
June 30, 2015 -66.88%
March 31, 2015 -10.40%
December 31, 2014 23.40%
September 30, 2014 -28.16%
June 30, 2014 -42.80%
March 31, 2014 -20.71%
December 31, 2013 -37.99%

Profit Margin Definition

Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.

Read full definition.

Profit Margin (Quarterly) Range, Past 5 Years

View Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Profit Margin (Quarterly) Benchmarks

View Profit Margin (Quarterly) Benchmarks
Start Trial
Swedencare AB 2.72%
Camurus AB 26.98%
Moberg Pharma AB -25.66%
Infant Bacterial Therapeutics AB --
AstraZeneca PLC 20.15%